Maureen R. Deehan

831 total citations
21 papers, 711 citations indexed

About

Maureen R. Deehan is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Maureen R. Deehan has authored 21 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Maureen R. Deehan's work include Parasitic Diseases Research and Treatment (6 papers), Cannabis and Cannabinoid Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Maureen R. Deehan is often cited by papers focused on Parasitic Diseases Research and Treatment (6 papers), Cannabis and Cannabinoid Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Maureen R. Deehan collaborates with scholars based in United Kingdom, Switzerland and Germany. Maureen R. Deehan's co-authors include Margaret M. Harnett, William Harnett, Katrina M. Houston, Helen S. Goodridge, Denise Williams, Elad Katz, Jiaqiang Cai, Matilda Bingham, R D Sturrock and W. Carson Brown and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Maureen R. Deehan

21 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen R. Deehan United Kingdom 16 280 220 209 180 119 21 711
Tarik Attout France 15 180 0.6× 212 1.0× 151 0.7× 242 1.3× 143 1.2× 20 695
E. Graeme Robertson United Kingdom 14 209 0.7× 107 0.5× 374 1.8× 121 0.7× 135 1.1× 23 856
Paola Ricciardi‐Castagnoli Italy 17 129 0.5× 84 0.4× 316 1.5× 1.1k 6.4× 46 0.4× 20 1.7k
H. J. Wellensiek Germany 9 191 0.7× 237 1.1× 285 1.4× 223 1.2× 24 0.2× 21 751
G Luffau France 13 100 0.4× 53 0.2× 148 0.7× 299 1.7× 83 0.7× 31 682
J A Sullivan United States 16 247 0.9× 308 1.4× 338 1.6× 264 1.5× 12 0.1× 23 1000
Judith A. Glaven United States 8 131 0.5× 48 0.2× 379 1.8× 98 0.5× 68 0.6× 8 776
Lucia Whitman United States 14 78 0.3× 175 0.8× 170 0.8× 220 1.2× 13 0.1× 23 725
Tawfik Aboellail United States 13 33 0.1× 201 0.9× 261 1.2× 59 0.3× 24 0.2× 43 719
Fabio Simbari Spain 12 343 1.2× 162 0.7× 802 3.8× 163 0.9× 271 2.3× 13 1.2k

Countries citing papers authored by Maureen R. Deehan

Since Specialization
Citations

This map shows the geographic impact of Maureen R. Deehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen R. Deehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen R. Deehan more than expected).

Fields of papers citing papers by Maureen R. Deehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen R. Deehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen R. Deehan. The network helps show where Maureen R. Deehan may publish in the future.

Co-authorship network of co-authors of Maureen R. Deehan

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen R. Deehan. A scholar is included among the top collaborators of Maureen R. Deehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen R. Deehan. Maureen R. Deehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deehan, Maureen R., et al.. (2016). Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance. Journal of Immunology Research. 2016. 1–15. 31 indexed citations
2.
Masternak, Krzysztof, Zoë Johnson, Vanessa Buatois, et al.. (2015). Abstract B54: Antagonizing CD47-SIRP alpha interaction with a bispecific antibody: A novel cancer immunotherapy approach. Cancer Immunology Research. 3(10_Supplement). B54–B54. 1 indexed citations
3.
Deehan, Maureen R., et al.. (2015). Managing unwanted immunogenicity of biologicals. Autoimmunity Reviews. 14(7). 569–574. 48 indexed citations
4.
Johnson, Zoë, Anne Papaioannou, Lucie Bernard, et al.. (2015). Bispecific antibody targeting of CD47/CD19 to promote enhanced phagocytosis of patient B lymphoma cells.. Journal of Clinical Oncology. 33(15_suppl). e14016–e14016. 7 indexed citations
5.
Adam, Julia M., John K. Clark, Takao Kiyoi, et al.. (2012). Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22(8). 2932–2937. 15 indexed citations
6.
Hatterer, Eric, F. Richard, Pauline Malinge, et al.. (2012). P156 Investigating the novel mechanism of action for NI-0501, a human interferon gamma monoclonal antibody. Cytokine. 59(3). 570–570. 15 indexed citations
7.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2011). Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(7). 2034–2039. 3 indexed citations
8.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2010). The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 497–501. 6 indexed citations
9.
Morrison, Angus J., Julia M. Adam, James Α. Baker, et al.. (2010). Design, synthesis, and structure–activity relationships of indole-3-heterocycles as agonists of the CB1 receptor. Bioorganic & Medicinal Chemistry Letters. 21(1). 506–509. 13 indexed citations
10.
Bingham, Matilda, Jiaqiang Cai, & Maureen R. Deehan. (2006). Eating, sleeping and rewarding: orexin receptors and their antagonists.. PubMed. 9(5). 551–9. 27 indexed citations
11.
Goodridge, Helen S., Maureen R. Deehan, William Harnett, & Margaret M. Harnett. (2004). Subversion of immunological signalling by a filarial nematode phosphorylcholine-containing secreted product. Cellular Signalling. 17(1). 11–16. 29 indexed citations
12.
Wilson, Emma H., Maureen R. Deehan, Elad Katz, et al.. (2003). Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES‐62 in vivo. Immunology. 109(2). 238–245. 44 indexed citations
13.
Deehan, Maureen R., Helen S. Goodridge, Derek Blair, et al.. (2002). Immunomodulatory properties of Ascaris suum glycosphingolipids – phosphorylcholine and non‐phosphorylcholine‐dependent effects. Parasite Immunology. 24(9-10). 463–469. 36 indexed citations
14.
15.
16.
Deehan, Maureen R., et al.. (1999). Immunomodulatory properties of a phosphorylcholine‐containing secreted filarial glycoprotein. Parasite Immunology. 21(12). 601–608. 70 indexed citations
17.
Harnett, Margaret M., Maureen R. Deehan, Denise Williams, & William Harnett. (1998). Induction of signalling anergy via the T‐cell receptor in cultured Jurkat T cells by pre‐exposure to a filarial nematode secreted product. Parasite Immunology. 20(11). 551–563. 58 indexed citations
18.
Deehan, Maureen R., Mhairi J. Frame, R. M. E. Parkhouse, et al.. (1998). A Phosphorylcholine-Containing Filarial Nematode-Secreted Product Disrupts B Lymphocyte Activation by Targeting Key Proliferative Signaling Pathways. The Journal of Immunology. 160(6). 2692–2699. 59 indexed citations
19.
Deehan, Maureen R., Margaret M. Harnett, & William Harnett. (1997). A filarial nematode secreted product differentially modulates expression and activation of protein kinase C isoforms in B lymphocytes. The Journal of Immunology. 159(12). 6105–6111. 56 indexed citations
20.
Lyall, Fiona, Maureen R. Deehan, Ian A. Greer, et al.. (1994). Mechanical stretch increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells. Journal of Hypertension. 12(10). 1139???1146–1139???1146. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tarik Attout Breakdown of academic impact, for papers by E. Graeme Robertson Breakdown of academic impact, for papers by Paola Ricciardi‐Castagnoli Breakdown of academic impact, for papers by H. J. Wellensiek Breakdown of academic impact, for papers by G Luffau Breakdown of academic impact, for papers by J A Sullivan Breakdown of academic impact, for papers by Judith A. Glaven Breakdown of academic impact, for papers by Lucia Whitman Breakdown of academic impact, for papers by Tawfik Aboellail Breakdown of academic impact, for papers by Fabio Simbari
Rankless by CCL
2026